• Mashup Score: 41

    Description: Evidence for the use of outpatient treatments in adults with confirmed COVID-19 continues to evolve with new data. This is version 2 of the American College of Physicians (ACP) living, rapid practice points focusing on 22 outpatient treatments for COVID-19, specifically addressing the dominant SARS-CoV-2 Omicron variant. Methods: The Population Health and Medical Science Committee (formerly the Scientific Medical Policy Committee) developed this version of the living, rapid practice points on the basis of a living, rapid review done by the ACP Center for Evidence Reviews at Cochrane Austria at the University for Continuing Education Krems (Danube University Krems). This topic will be maintained as living and rapid by continually monitoring and assessing the impact of new evidence. Practice Point 1: Consider molnupiravir to treat symptomatic patients with confirmed mild to moderate COVID-19 in the outpatient setting who are within 5 days of the onset of symptoms and at a hi

    Tweet Tweets with this article
    • New COVID19 Living Guidelines for Omicron   📍These are @ACPIMPhysicians evidence-based recs 📍No column for LongCOVID prevention (ie, no data 😵‍💫) 📍What strikes me is how many “NO EVIDENCE” spots remain 📍Ivermectin still on #naughty list   https://t.co/B1qmKoAqBE https://t.co/oV14uyAaT0

  • Mashup Score: 6

    “Science is magic that works.” Kurt Vonnegut #RESEARCH Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations – The Lancet Respiratory Medicine Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness – The Lancet Respiratory Medicine Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update – Molecular Psychiatry Myocarditis […]

    Tweet Tweets with this article
    • RT @LongCOVIDemail: The Long COVID Newsletter issue #28 is now available: https://t.co/LEoFEXf7cT… #LongCovid #LongCovidKids In the news th…